Speaker:
Pierluigi Paracchi: CEO Genenta Science
Speaker:
Richard Slansky: CFO Genenta Science
Title: Reprogramming macrophages using autologous hematopoietic stem cells as immunotherapy for glioblastoma: TEM-GBM study (NCT03866109)
Type: Poster
Presenter: Prof. Fabio Ciceri, Head of Hematology and Bone Marrow Transplantation Unit – San Raffaele Hospital
The Event is promoted by Amcham’s Bowling Green Bull, an initiative to connect Italian companies, entrepreneurs and top managers aiming for international growth and expansion in their interactions with U.S. financial markets and investors. Special Guest Karen Snow, Senior Vice President, Head of U.S. Listings and Revenue, Pierluigi Paracchi, CEO and Co-founder Genenta, Claudio Erba, CEO and Co-founder Docebo, Mauro Carobene, Chief Business Officer Kaleyra
Title: Autologous macrophage-based immunotherapy Induces a pro-inflammatory state in GBM tumor microenvironment - (TEM-GBM)
Type: Poster
Presenter: CMO Carlo Russo
Time: November 10-11, 9:00 AM – 8.30 PM ET
Title: Genetically-modified hematopoietic stem cells as a one-time, systemic treatment for non-hematologic disorders
Type: Oral
Presenter: Bernhard Gentner, SR-TIGET, Milan and Co-founder of Genenta
Time: October 12, 11:10 AM -1:15 PM BST
Tap Room - 3rd Floor
Speakers:
Pierluigi Paracchi, CEO and Co-founder Genenta Science
Carlo Russo, CMO Genenta Science
Speakers:
Pierluigi Paracchi, CEO
Carlo Russo, CMO
Presenter:
Pierluigi Paracchi, CEO and Co-founder Genenta Science
Presenters:
Carlo Russo, CMO
Title: You Can't Get Anywhere without the CAR-t Keys or GMP Van: Why Manufacturing is Essential (panel presentation)
Presenters:
Pierluigi Paracchi, CEO
Carlo Russo, CMO
Richard Slansky, CFO